Literature DB >> 412720

The use, in diabetic rats and monkeys, of artificial capillary units containing cultured islets of Langerhans (artificial endocrine pancreas).

A M Sun, W Parisius, G M Healy, I Vacek, H G Macmorine.   

Abstract

A unit was constructed that consisted of a core of hollow fibers through which low-molecular-weight substances, such as glucose and insulin, could pass freely but were impermeable to high-molecular-weight proteins, such as antibodies. Islets of Langerhans from normal rats were planted in the space surrounding the fibers, and either blood or nutrient medium was circulated through the fibers themselves. In experiments with animals, the units were attached to the vascular system of diabetic rats and monkeys. Blood glucose concentrations in the rats were reduced to nondiabetic levels within one hour and were maintained for the duration of the experiments. In monkeys the blood glucose level declined from 210 mg./100 ml. to 90 mg./100 ml. in four hours and insulin in the serum rose to 93 muU./ml. in one-half hour. Also, we have found that islets from monkeys cultivated in the artificial endocrine pancreas (AEP) continue to release insulin into circulating tissue culture medium for over eight months.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412720     DOI: 10.2337/diab.26.12.1136

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

Review 1.  Alternatives to immunosuppressive drugs in human islet transplantation.

Authors:  Alison Anne Cotterell; Norma Sue Kenyon
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 2.  Prospects for pancreatic islet transplantation.

Authors:  D W Gray; P J Morris
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

Review 3.  Encapsulated Islet Transplantation: Where Do We Stand?

Authors:  Vijayaganapathy Vaithilingam; Sumeet Bal; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2017-06-12

Review 4.  Islet transplantation and encapsulation: an update on recent developments.

Authors:  Vijayaganapathy Vaithilingam; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2011-05-10

Review 5.  Islet and stem cell encapsulation for clinical transplantation.

Authors:  Rahul Krishnan; Michael Alexander; Lourdes Robles; Clarence E Foster; Jonathan R T Lakey
Journal:  Rev Diabet Stud       Date:  2014-05-10

Review 6.  Inorganic nanoporous membranes for immunoisolated cell-based drug delivery.

Authors:  Adam Mendelsohn; Tejal Desai
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

7.  Controlled release micropump for insulin administration.

Authors:  M V Sefton; H M Lusher; S R Firth; M U Waher
Journal:  Ann Biomed Eng       Date:  1979       Impact factor: 3.934

8.  Cultivation of recombinant, insulin-secreting AtT-20 cells as free and entrapped spheroids.

Authors:  K K Papas; I Constantinidis; A Sambanis
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 9.  Islet immuno-isolation: the use of hybrid artificial organs to prevent islet tissue rejection.

Authors:  D W Scharp; N S Mason; R E Sparks
Journal:  World J Surg       Date:  1984-04       Impact factor: 3.352

Review 10.  Islet microencapsulation: a review.

Authors:  H A Clayton; R F James; N J London
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.